Shares of Athersys traded down 3.38% during mid-day trading on Thursday, hitting $1.43. Athersys has a 52 week low of $1.00 and a 52 week high of $2.90. The company’s market cap is $42.0 million.
Separately, analysts at Piper Jaffray (NYSE: PJC) initiated coverage on shares of Athersys in a research note to investors on Tuesday, March 20th. They set an “overweight” rating and a $4.00 price target on the stock.
Athersys, Inc. is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and improve the quality of human life.